HKSE - Delayed Quote HKD

NATURAL BEAUTY (0157.HK)

Compare
0.470
-0.010
(-2.08%)
At close: March 28 at 3:34:05 PM GMT+8
Loading Chart for 0157.HK
  • Previous Close 0.480
  • Open 0.475
  • Bid 0.455 x --
  • Ask 0.485 x --
  • Day's Range 0.450 - 0.475
  • 52 Week Range 0.440 - 0.590
  • Volume 190,000
  • Avg. Volume 45,245
  • Market Cap (intraday) 940.987M
  • Beta (5Y Monthly) -0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -0.050
  • Earnings Date Feb 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 1, 2022
  • 1y Target Est --

Natural Beauty Bio-Technology Limited, an investment holding company, offers skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, aroma-therapeutic, beauty, health supplements, and make-up products under the Natural Beauty brand. The company also offers skin treatment, skin care consulting, medical cosmetology, and beauty consulting and training services. In addition, its spas provide hydrotherapy, facial treatment, body care, and skin care analysis services; skin care consulting; and beauty apparatus. Further, the company engages in the wholesale of skin care and beauty products. Natural Beauty Bio-Technology Limited was founded in 1976 and is based in Causeway Bay, Hong Kong.

www.ir-cloud.com/hongkong/00157/irwebsite/

542

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0157.HK

View More

Performance Overview: 0157.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0157.HK
3.09%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

0157.HK
4.08%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

0157.HK
17.06%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

0157.HK
26.93%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 0157.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0157.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    940.99M

  • Enterprise Value

    1.04B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.66

  • Price/Book (mrq)

    2.10

  • Enterprise Value/Revenue

    2.93

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.30%

  • Return on Assets (ttm)

    -3.75%

  • Return on Equity (ttm)

    -20.27%

  • Revenue (ttm)

    353.65M

  • Net Income Avi to Common (ttm)

    -103.61M

  • Diluted EPS (ttm)

    -0.050

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    119.44M

  • Total Debt/Equity (mrq)

    47.39%

  • Levered Free Cash Flow (ttm)

    -38.78M

Research Analysis: 0157.HK

View More

Company Insights: 0157.HK

Research Reports: 0157.HK

View More

People Also Watch